Shares of HealthEquity, Inc. (NASDAQ:HQY - Get Free Report) have been assigned a consensus recommendation of "Buy" from the thirteen research firms that are currently covering the firm, Marketbeat reports. One analyst has rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating on the company. The average twelve-month price objective among brokerages that have issued a report on the stock in the last year is $113.31.
Several research analysts have issued reports on HQY shares. Barrington Research reiterated an "outperform" rating and set a $112.00 price objective on shares of HealthEquity in a research note on Friday, March 14th. Mizuho started coverage on shares of HealthEquity in a report on Wednesday, December 4th. They set an "outperform" rating and a $126.00 price target for the company. KeyCorp decreased their price objective on shares of HealthEquity from $120.00 to $110.00 and set an "overweight" rating on the stock in a research note on Monday. Royal Bank of Canada lifted their target price on shares of HealthEquity from $100.00 to $105.00 and gave the company an "outperform" rating in a research note on Tuesday, December 10th. Finally, Wells Fargo & Company increased their price target on HealthEquity from $110.00 to $125.00 and gave the stock an "overweight" rating in a research report on Wednesday, February 26th.
Check Out Our Latest Analysis on HQY
Insider Activity at HealthEquity
In other HealthEquity news, Director Robert W. Selander sold 5,750 shares of the firm's stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $111.29, for a total value of $639,917.50. Following the transaction, the director now directly owns 78,219 shares of the company's stock, valued at approximately $8,704,992.51. This trade represents a 6.85 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 2.20% of the stock is owned by company insiders.
Institutional Inflows and Outflows
Several hedge funds and other institutional investors have recently made changes to their positions in the stock. KBC Group NV lifted its stake in HealthEquity by 16.1% in the third quarter. KBC Group NV now owns 2,463 shares of the company's stock valued at $202,000 after buying an additional 341 shares during the period. Swiss National Bank raised its position in shares of HealthEquity by 0.4% in the 3rd quarter. Swiss National Bank now owns 169,900 shares of the company's stock valued at $13,906,000 after acquiring an additional 600 shares during the period. Connor Clark & Lunn Investment Management Ltd. boosted its stake in HealthEquity by 28.6% during the 3rd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 109,162 shares of the company's stock worth $8,935,000 after acquiring an additional 24,266 shares during the last quarter. King Luther Capital Management Corp grew its holdings in HealthEquity by 1.2% during the third quarter. King Luther Capital Management Corp now owns 45,847 shares of the company's stock valued at $3,753,000 after purchasing an additional 552 shares during the period. Finally, Intech Investment Management LLC increased its stake in HealthEquity by 59.5% in the third quarter. Intech Investment Management LLC now owns 21,064 shares of the company's stock valued at $1,724,000 after purchasing an additional 7,859 shares in the last quarter. 99.55% of the stock is currently owned by institutional investors.
HealthEquity Price Performance
Shares of HQY stock traded down $0.13 during trading hours on Friday, hitting $90.19. The company had a trading volume of 2,054,483 shares, compared to its average volume of 697,297. HealthEquity has a 12 month low of $65.01 and a 12 month high of $115.59. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The firm's fifty day moving average is $104.67 and its 200 day moving average is $95.84. The firm has a market capitalization of $7.80 billion, a price-to-earnings ratio of 82.74, a PEG ratio of 1.60 and a beta of 0.62.
About HealthEquity
(
Get Free ReportHealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
See Also
Before you consider HealthEquity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthEquity wasn't on the list.
While HealthEquity currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
